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OBJECTIVE: The objective of this systematic review is to verify whether or not 
Melatonin has a significantly positive effect on nigbt -shift workers' overall recovery, 
mcx.xl. tiredness, alertness, attention. and sleep quality. 
STUDY DESIGN: This study evaluates the data proven by three English primary studies 
dated 1998,2000. and 2005. 
DATA SOURCES: Randomized. double blind. placeb<:K:ontrolled trials which evaluates 
the effect of Melatonin vs placebo pill on a group of night-sbift workers. 
OUTCOMES MEASURED: The outcomes that are measured in these randomiled 
controlled trials include: improvement of sleep quality, dUI'~tion of tiredness, sleep 
latency. and general state during daytime hours. Profile of Mcx.xI States Questionnaire is a 
measurement medium that is used in all three studies. This medium contains 65 
adjectives. which are rated on a 5 IX'int scale. Other mediums that are used throughout 
the three studies are Visual Analog Scale, neurophysiologic testing. Actinigrnph 1000, 
StandfOrd Sleepiness Scale, The Connors Continuous Performance Test J. 
RESULTS: All of the data from each of the studies illustrated that there wa.> not a 
significant difference noted between the experimental groups and the control groups. 
CONCLUSION: The results from the trials included in this review verified that 
Melatonin does not have a significantly IX'sitive effect on night -shift "!orkers' recovery, 
mcx.xl, tiredness. alertness. attention, and sleep quality. 
KEY WORDS: "Night-Shift Worker", "Melatonin Effects" 
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introduction 
Melatonin is widely knov,,," for its sleep promoting charactcristics: howcvcr, its cfficacy 
in promoting quality sleep has rare ly been studied.' One m~in population that may benefit from 
the slcep promoting qualities of Mclatonin is night shift workers who desire bener sleep after a 
night of work. Nearly 25% of workers in the US panicipate in shift work. The majority of these 
workers complain of exee,silt slcepine,;s throughout the day at the worksite and lack of sleep at 
homc.~ However, the c:< a<:t pathological mechanism of this is unknown. Melatonin is a naturally 
occurring hormone produced in the body that normalizes the sleep·wake cyele.1.l When an 
e:<ogenous source of this hormone is introduced, in addition to the normal levels that are present. 
it may funher promote better sleep habits. U This paper evaluates three randomized controlled 
trials comparing the effect of Melatonin on improving sleep quaEt y. duration of tiredness, sleep 
latency. and general mood state during daytime compared 10 a placebo pill . If proven to be 
beneficial in this population, Melatonin could significantly improve Ihei r lifestyle and result in a 
beller performance during their next shift. 
This substance. if provcn to be helpful and effective. could make a major differencc in 
nearly all Americans. 1 )" Majority of Americans use unhealthy options to fuel lhei r energy. 
According to Consumer Repons. nearly 500 million dollars is spent yearly on energy drinks 
alone. l Melatonin could be a healthy and cost-effective alternative to this unhealthy addiction to 
caffeinated beverages. Many Americans who work the night shift suffer from drowsincss. 
trouble readjusti ng to their normal sleep· wake cycle. change in mood. and lack of alenness. 
Thcre are numerous medical conditions such as Depression. Hypcnension. and Coronary Anery 
Disease that may be caused by a lad of sleep.'·J.· Howcver. Ihe cxact pathological mechanism of 
this relationship is unknown. Thc majority of individuals treat their lack of sleep with lifestyle 
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modifications, over the counter methods. and prescription medications. These methods only treat 
the symptom of fatigue. whereas. Melatonin essentially treats the problem and promotes better 
sleep which directly provides wakefulness. Lifestyle modifications inelude exercise and cold 
shower. Over the counter methods inelude energy drinks (Monster. Red Bull. etc.), 
coffee/espresso shots. and caffeine pills. Provigil and Nuvigil are examples of pres.:ription 
methods. Many times the alternative methods mentioned above are used to substitute for sleep. 
and the majority of them are unhealthy. They often allow energy for an allotted time and almost 
always lead to a "cr.I,h", eventually leaving individuals feeling e,'en drowsier. Melaton in, 
however, is a healthy alternative to caffeine sources. It promotes healthy sleep habits and allows 
individuals to feel rejuvenated continuously. I.H 
Objective 
The objective of this systematic review is to determine whether or not "Does Melatonin 
have a significantly positive effect on night shift workers ' overall recovery. mood. tiredness. 
alenness. and sleep quality?" My hypothe,i> is that Melatonin will be effective for overall 
recovery. mood, tiredness. alennes" and sleep quality . 
Methods 
Several methods were used in the selection of these studies. The criteria for the selcction 
of the studies melude; population. interventions, comparisons. outcomes. and the desired type of 
study. The population criteria consist of males and females between the age of twenty -eight and 
fony-five who work night shift. I.J.4 Interventions that were used in the studies were Melatonin 
tablets at variable dosages. This Melatonin tablet had to be compared to a visually identical 
placebo pill in all the studies. Outcomes that were measured in all of the selected studies had to 
inelude: overall recovery, mood, tiredness, alenne:is. and sleep quality. All of the studies had to 
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be randomi~ed. double blind. placebo controlled, crossover trials comparing dosages of 
Melatonin vs placebo and its effect on night shift workers,l.l.4 To altain the data sources. "night 
shift workers" and "melatonin effects" were the keyv.'ords used in the search box. All studies hud 
to be written in English and had to be published in peer-reviewed medical journals,I.) .• The 
research was perfonned using Mcdhne and OVlO dutabascs through the Cochrane medical 
database. All anicles were selected based on the importance of outcomes to the patient 
(POEMS ), Inclusion criteria included any studies that were nmdomized. control led. prospective. 
considered POEMS. and published after 1996. Exclusion crileria included any study that 
evaluated patients under the age of 18 or those who were not a night shift worker. I.). The 
statistical medians u>ed to report the outcomes included: VAS global assessment of rttovery. 
Fischer's exact test, paired T test. Wilcoxon signed nlnk test. SSS and TMB measurement. 
Conners Continuous Perfonnanee Test, p-values. confidence intervals. tJ.4 Table I outlines all 
the major aspects of all three randomized control trials that were evaluated. All three of the trials 
contained only continuous data that could not be con"ened to dichotomous data. All articles had 
varying dosages of Melatonin. however, they all yielded similar end results,l.l·~ 
Outcomes Measured 
The outcomes measured in all three ReTs were variables that were re levant to the 
patient such as: overall recovery. mood. tiredness. alertness. and sleep quality, 1.14 All three 
randomized controlled trials measured at least one of their outcomes by using the Profile of 
Mood questionnaire. The POMS contains 65 adjcctives which arc all rated on a 5-point scale. 
The analysis of this survey allows the experimenter to obtain data about mood states such as: 
tension-anxiety. depression-dejection. anger-hostility. vigor·act i vity. fatigue-inertia. and 
confusion-bewildennenLI.l.4 In the Wright study. the PO:>1S were admini,tered every morning 
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Table I : Rcsults of Demographics of Included Studic~' '''''' 
STUDY TYPE 1/ PTS (~G~) INCLUSION EXCLUSION CRITIERIA WID INTERVENTIONS YRS CRITERIA 
Wright. Doublc blind 
" 
32 - 45 All faculty Facuity who did not work , Melatonin 5mg or placebo for 3 
1998 ( I) placebo members in Dept nights. pregnant or coosecuth'e nights aftcr night shift 
controlled of Emergency lactating womcn. subjects duty with crosso"er to the opposite 
RCT Medicine at taking melatonin within 30 agent after a subsequent block of 
crosso,'cr trial Vanderbilt days of trial period. mid night shifts 
Univcl'>ily subjects tak ing ,neds with 
sedmi"e propenics at the 
time oftllc trial 
Jackovi'h Double blind 19 28.2 Any willing EM Heavyalcolml usc (>2 0 Subjects were mndomized to 
2(0) (2) placebo resident who drink.,Jday). extrcme receive either melatonin I mg or 
COntrolll.'tl worked t,,·o series caffeine use (>6 placebo, 30 to 60 minutes prior to 
RCT of at least three eaffeinated drinks/day). their daytime sleep session, for 3 
crossover trinl consecutive night opioid or bcnzodiazepine consecutive days after each night 
shifts separated by use. rest less leg syndrome. ,hift. Cross over to the other agent 
at least one "'cck or periodic limb movement occurred during thcir subsequent 
of day shifls d isorder. niltht shifts. 
C;lvallo, Double blind 
" 
211 .6 ± Being;l second Presence of infant- or 0 P~r1ieipants lOok mclutonin 3mg or 
2005 (3) placebo 1.9 years year reside nt todd lers in the household. u placebo befure bedt ime in the 
controlled scheduled for 2 chronic illnc.>s. pregnancy, 'Horning afler night shift; 
ReI' night floot prescHt or past depre, .• ion. complctl.'tl a sleep diary and 
crossover trial rowtions and being usc: of scdati ve or h ypnOlic udvcrM: effects questionnaire daily; 
willing to refrain drugs during 2 weeks :IIId completed the profile of mood 
from alcoholic preceding each period of ~tatc:s and the Conners continuous 
liquids and the study, usc of pc:rfonnance Test 3 limes in each 
sedative drugs exogenous melatonin. and study week to lest mood and 
during any period usc of light treatment attention. respect ively 
of the study deviccs 
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on Days 1 to 4 to assess behavior and mood levels.' In the Jockovich trial. POMS was used to 
mea,ure the nighttime mood and drowsiness. The POMS survey wa, administered to all 
panicipants just prior 10 each night sh ift throughout the entire length of study,' In the Cavallo 
trial, POMS survey was administered to the panicipants at the end of each night shift.) There 
were several additional surveys used in the studies. The Wright trial measured the primary 
outcomes in their study by using the Visual Analog Scale (VAS). Neuropsychological testing 
was aho performed to measure the outcomes, The secondary outcomes measured in this study 
were sleep quality. duration. and tiredness. ' In addition to POMS. the Jockovich trial measured 
their outcomes by using the Actigraph 1000 and Stanford Sleepiness Scale." The Cavallo trial 
measured their outcomes by u,ing The Connors Continuous Performance Test 3 also_ 
Re,uits 
The Wright study was composed of 12 male and 3 female emergency physicians whose 
average age was 38.6. Some exclusion criteria for this study in panicular were women who were 
pregnant or lactating. anyone who has taken Melatonin within 30 days before the trial is initiated. 
and anyone who was taking a medication that had .cdative effeclS. ' The data from all three RCTs 
was broken down into two subsets: e xperimental group. which included those taking Melatonin 5 
mg and the control group which included tho>c taking the placebo pil1. '·)" Table 2 illustrates the 
relationship between Melatonin and placebo and their effect on sleep quality and latency in the 
Wright study, Eight of the physic ians were given placebo treatment initially. while the remaining 
7 were given Melatonin 5 mg_' to this study all patients ",ere presented as an intention to treat 
(m) analysis. The effects of Melatonin vs placebo were measured by four as]JC<:ts of sleep 
which included: sleep latency. hours of sleep per night. night awakenings. and early awakenings. 
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On night I. the percentage of early awakenings was equal between the experimental group and 
the control group. Howcver. on the second and th ird night the control group had more ea rl y 
awakenings. For the remaining three variables. the calculated measures were similar between thc 
experimental group and the control group for all three nights .' All of the calculated dma proved 
to show an insignificant difference. In addition to these four factors. a global <lSr.c:ssment of 
recovery VAS was performed on the morning of the fourth day and revealed the Melatonin 
group recovery >cores to be 60.5 ± 16.9 vs placebo scores which were 58.9 ± 14.5. The mean 
improvement was 1.6 and indicated a Cl of 95%. 1be p-value for thi, study mea,ured to be 
0.29. 1 The p-value. being less than 0.05. showed a decreased relationship and statistical 
irrelevance between the Melatonin therapy and the control therapy. POMS was also administered 
to the patients and then evaluated. This survey showed Ihat there waS a significant difference in 
scores in relation to the number of days. This indicated that as the days progressed. the 
participants saw a ]XIsitive change in the effect of Melatonin. However. this considerable 
difference was common among the placebo patients as ,,·ell. ' For this reason. it can not be 
concluded that Melatonin was superior to placebo. As the days progressed from day 1 to day 4. 
the t value for POMS went from 42.5 to 40 for both group,. The p-values for both treatment arms 
were 0.01 which proves that there i, a ]XIsi ti ve correlation. If this p-value was only present in 
Melatonin. then the data would be substantial enough to prove that Mclmonin does playa 
statistically ]XIsitivc role in its effectiveness. However. due to its presence in both group>, this 
data is rendered insi gnificam. All other outcomes that wcre asscsr.c:d did not contain any re levant 
differences. ' The compliance amount was not mentioned in this study. In thi s study. the NNH 
was interpreted in the form of adverse events and its sewrity. The tolerability score for 
Melatonin and placebo was 86.2 ± [3.9 and 82.5 ± 21.5, respectively. The scores had a p-value 
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of 0.93 showing a decreased correlation between the two subjects at question. ' The most 
common side effects mentioned by the partic ipants from both treatment arms were headache. 
wakefulness. nightmares , and nausea. The adver,;e effects are depicted and compared to the other 
RCTs in Table 6.1.3·4 
Table 2: i\1elatolJin Vs Placebo - Wri ht Stu d ' 
Night Slffp Hours sleep Night awakenings Early lalenc~I';run) ner night awakenin!!s 
Night 1 Melatonin 28 ± 19 7.3±JA 2.6± IA 20% 
Placebo 18 + 15 7.2 + 1.2 1.9 + 2.0 20% 
Night 2 Melatonin 2 1 + 17 7.4 +.9 1.6 + 1.3 0% 
Placebo 25 +2 1 7.2+1.1 1.7 + 1.0 7% 
Ni ht 3 Melatonin 18 + 16 7.3 + 1.0 1.2+L5 0% 
Placebo 14 + 14 7.1 + 1.1 1.1+1.1 7% 
The Jockovich study contained nineteen residents from the University of Florida 
emergency medicine department whose mean age was 28.2. The exclusion criteria included the 
following: greater than two alcohol ic drinks per day. greater than six caffeinated beverages per 
day. any opioid or benzodiazepine usage. restless leg syndrome. or periodic limb movement 
disorder. All of these criteria would interfere in interpreting the results to a sleep study since all 
of these factors playa major role in the amount and quality of sleep any individuals get. The 
experimental group received I mg of ~1elatonin. whereas. the control group consumed a visually 
identical placebo pill. Profile of Mood States and Stanford Slcepiness Scale (SSSl were the two 
surveys used to measure the levels of mood and sleep. respective ly. The SSS showed a baseline 
score of 1.8846. The score for patients laking Melatonin was 2.2571. whereas. those taking the 
placebo was 2.1282. The p-value of the SSS was o.oon. There wa, not a significant difference 
between the score of the participants taking Melatonin vs plucebo. The Profile of Mood States 
measured the total mood disorder ([MOl faClor and determined baseline of 5.769. TMO results 
for Melatonin were 12.212 and results for placebo were 5.585. The p-value for TMD was 0.9329. 
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Both of the p values exceeded 0.05 which indicated poor conelalion and proved the results to be 
statistically insignificant. Thes.c re~ults are depicted in 'I'abll" 3. Sleep latency and efficacy "'ere 
also measured. The experimental group and the placebo group mew;ured 90.98% and 91 16%, 
respectively. for the measure of sleep efficacy. For sleep latency. the data for the experimental 
group was 7.59 minutes. whereas. 6.80 minutes for the placebo group. The p-value for sleep 
efficacy and sleep latency was 0.9318 and 0 .6739. respectil'ely.4 There was 100% complianee in 
relation 10 the drug administration am! consumption. except for one incident in which the drug 
was taken 15 minutes before the intended sleep s.cssion mther than the recommended 30 - 60 
minutes. There was no confidence interval addressed in [he anicl .. : llle NNH was interpreted in 
the form of ad,'erse evcnts and the tolerability of the c;o;perimental drug. The only ~ignifican1 
adverse effects that "'ere reponed by patients were vivid dream. for one night and difficulty 
.witching back [0 a nonnal nighuime sleep intef'\·al. No othcr ad"ersc effects "'ere reponed: 
The participants m this study were nOi presented in an intention·to-treat analysis. There are some 
variables that might have affected the outcome of this study. Three participants did not complete 
cither the SSS or PO:' IS. or both for one night shift. Thus. this night was not recorded for its 
rnults. Also. it had a small sample size and lacked standardized night schedules for all 
participants. This factor made it difficult 10 compare lhe result to the greatest competency.' 
TABLE 3: Comparison of SSS and PO.\IS Resulls betwet'n Expt"rimental group ' "S Control 
eroup' 
J ocko,'k h 2000 Stud .. SSS PO'\IS 
Baseline 1.8846 5.769 
Melatonin 2.2571 12.212 
Placebo 2.1282 5.585 
P Value 60" .9329 
The Cavallo study contained pedialric residents who were willing to ,ustain from 
alcoholic beverages and sedative or hypnotic drug. during each period of the study. The effect of 
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3 mg of Mciatonin on these night shift workers was measured and evaluated. The exclusion 
criteria for this study were those residents with infants or toddlers in the household, those with 
any chronic illnes5e5. pregnancies. and past or present depression.J All oftllese factors have an 
impact on the normal sleep wake cycle of an individual. >0 if a negati.'e efficacy was secn, the 
experimenters are unable to attribute it to the mediCation or to the environmental factors. 
Participants refrained from takiog tlleir pill if it was later than 13:00 hours. This was done to 
prevent any delayed effects from the Melatonin pills that may affccttheir pcrfonnance on their 
neXI night shift ] In this study the individuals were not presented in an intention-to-treat analysis 
manner. Three measures evaluated in this study included: sleep. anention. and mood. A sleep 
diary measured each panicipant's sleep quality. The test of anention was measured and evaluated 
by the Conners" Continuous Perfonnance Test. The test used to evaluate mood was the Profile of 
Mood States.J When evaluating the calculation on sleep quality. no statistically significant 
difference was nOied bet"'een tile two subsets. This study was separated into "morning treatment 
days" and "'all days" The "'morning treatment days" accounted for the days Melatonin was laken 
before 1300 hours. The "'all day" subset including lhe day following each night shift and any day 
tile panicipant did nOl work the night shift. Sleep quality calculation on the morning lreatment 
days soowed a score of 60.8 ± 19.6 for the placebo pill and 62.6 ± 17.7 for those laking 
Melatonin. The p-value for this subset was 0.26.3 The calculation and p-value proved Ihal Ihe 
difference belween the placebo pill and Melatonin was insignificant The data gathered for tile 
anemion survey which soowed a significant difference is illustrated in Table 4. No statistical 
difference was noted belween the Iwo groups of participants for Ihe following variables: number 
of commission errors. means reaction time. altentiveness. risk taking. and hit reaction time block 
change.) Ho"'C\·er. for lhe variable "number of omission errors"', it "'as proven to have a 
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significantly lower rdle with Melatonin than the placebo pill. Melatonin was 3.0 ± 9.6 and 
placebo was 4.5 ± 17.5 with a p value of 0.03. Since the p value was les, than .05. it was proven 
to carry a significant differen<:e .l Ta ble 5 depicts the data from the POMS survey evaluating 
mood and suppons the conclusion that no statistically significant difference was noted between 
the e"perimental group and [he placebo group. For example. anger-ho;;tility is one of the 6 
variables measured in the POMS survey. This variable measured out to be 3.9 ± 5.9 for the 
placebo and 3.9 ± 7.3 for Melatonin. with a p value of 0.S3. ) There was no confidence interval 
calculated in this anicle , NNH was reported in terms of side effects and tolerability of the 
experimental drug. The majorities of adverse effects reponed were minimally significant and had 
u p--vulue of 0.09. Adverse effects included: headache. abdominal pain. nausea, vomiting, 
diarrhea. excessive sleepiness. nightmares. or dinines,.l Tahle 6 further depicts the adverse 
events that .... 'ere noted In each of the RCTs. l.lA 
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Table 6: Comnarin Ad.-erse E,-ents or all RCfs 
H~ada<'" Abdominal N.u"'~ Vomiting Diarrhea E,,,,,,, Nightmares Vi,-id 
;. S"' iDe" Ilreams 
\\'ri ", , , X 
J""ko.-j<h , 
C.'-ano , X X X X X , 
Discu,~ion 
The Wright and lockovich ,mdies mentioned Melutonin's ubi lily 10 treat jet lag and 
insomnia. I.' They agree that Melutonin is used as a dietary supplement throughout the US. It has 
not been reviewed by the Food and Drug Administralion. Since il is considered a dietary 
supplement. it can be obtaincd over the counter ut general he~lth food stores. I . There are r.everal 
limitations that were presented in ~IJ the RCTs. For example. in the Wright and l ockovich 
studies, the p~rticipants were those who have intermittent night shifl work. Those who haw 
worked Ihe night for long period of time are superior subjects for evalumion because there is 
more of a chance that they will be able to ide nti fy the most minute changes in variables such as 
alertness. sleep quality, etc. U Another limitation that present in all three RCTs was that each 
study had a smal l number of subje>:ls and trials lengths were relat ively short. A larger subject 
group and longer trial time yields more reliable data.l.l.4 In the Cavallo study, there was no 
designated sleep time. This could be an advantage because il shows how Melatonin works in a 
natural environment and not just in a controlled environment. It can also be detrimental to the 
study since it can dei:rear.e the experimenter's ability to adequately compare the subjects_ 
Conclusion 
Through ther.e studies, it can be concluded that Melatonin docs not have a significantly 
positive effe>:t on night -shift workers overall recovery, mood. tiredness. alennc.>s. and sleep 
quality .' ,J.4 This conclusion is veri lied in all of Ihe included rdndomiled controlled trials. All of 
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